News & Views

  • Siemens adds Diagnostics to China Manufacturing Capability
    Franz Walt
  • George Chan

Siemens adds Diagnostics to China Manufacturing Capability

Oct 11 2016 Read 2178 Times

The expansion of its infrastructure operations to include in-country manufacturing capabilities for clinical chemistry and immunoassay reagents in China, has been announced by Siemens Healthineers. The company is to extend its existing manufacturing operations in Shanghai to include a new in vitro diagnostics facility. “This investment demonstrates the company’s continued commitment to address the evolving needs in the Chinese market and in healthcare markets across the globe,” said Franz Walt, President, Laboratory Diagnostics, Siemens Healthineers.

China is the second largest market for the company. According to George Chan, President, Greater China, Siemens Healthineers, “The opening of this facility strengthens our ability to support Chinese healthcare reform as we deliver better outcomes at a lower cost to our customers.” The business expects to add hundreds of additional employees once the project is complete.

In May this year Siemens Healthcare formally changed its name to Siemens Healthiners, chosen to embody the company’s pioneering spirit and engineering expertise in the healthcare industry. This has given a new identity to the organisation and to the people – the people accompanying, serving and inspiring healthcare providers worldwide – the people behind outstanding products and solutions, said the company.

Reader comments

Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.

Post a Comment

Digital Edition

Lab Asia December 2020

December 2020

In This Edition Articles - The Movement Towards More Comprehensive Testing of Mycotoxins in Cannabis - Addressing proper HACCP implementation - Micropatterning: The art of micro-controlling...

View all digital editions



Feb 23 2021 Cologne, Germany

IFPAC Annual Meeting

Feb 28 2021 Virtual event

SIAF Guangzhou

Mar 03 2021 Guanghzou, China


Mar 08 2021 Virtual Event

Bio-Europe Spring

Mar 22 2021 Digital event

View all events